Line 1: |
Line 1: |
− | Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
| + | == Myeloproliferative Neoplasms (MPN) == |
− | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | + | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] |
− | **[[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]]
| + | *[[Chronic Neutrophilic Leukemia (CNL)]] |
− | **[[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]]
| + | *[[Polycythemia Vera (PV)]] |
− | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]] | + | *[[Primary Myelofibrosis (PMF)]] |
− | **sub division | + | *[[Essential Thrombocythemia (ET)]] |
− | ***sub-sub-sub division | + | *[[Chronic Eosinophilic Leukemia, Not Otherwise Specified]] |
| + | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] |
| + | |
| + | == Mastocytosis == |
| + | *[[Cutaneous Mastocytosis]] |
| + | *[[Systemic Mastocytosis]] |
| + | *[[Mast Cell Sarcoma]] |
| | | |
| + | == Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) == |
| + | *[[Chronic Myelomonocytic Leukemia (CMML)]] |
| + | *[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]] |
| + | *[[Juvenile Myelomonocytic Leukemia (JMML)]] |
| + | *[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] |
| + | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] |
| | | |
| == Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms == | | == Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms == |
Line 76: |
Line 88: |
| *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] | | *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] |
| *[[Refractory Cytopenia of Childhood]] | | *[[Refractory Cytopenia of Childhood]] |
− |
| |
− | == Myeloproliferative Neoplasms (MPN) ==
| |
− | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]]
| |
− | *[[Chronic Neutrophilic Leukemia (CNL)]]
| |
− | *[[Polycythemia Vera (PV)]]
| |
− | *[[Primary Myelofibrosis (PMF)]]
| |
− | *[[Essential Thrombocythemia (ET)]]
| |
− | *[[Chronic Eosinophilic Leukemia, Not Otherwise Specified]]
| |
− | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]]
| |
− |
| |
− | == Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ==
| |
− | *[[Chronic Myelomonocytic Leukemia (CMML)]]
| |
− | *[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]]
| |
− | *[[Juvenile Myelomonocytic Leukemia (JMML)]]
| |
− | *[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]
| |
− | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
| |
| | | |
| == Precursor Lymphoid Neoplasms == | | == Precursor Lymphoid Neoplasms == |